Skip to main content
NIH funding notice PAR-19-307

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)

Closed on September 10, 2020.

Posted
June 28, 2019
Close date
September 10, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,519,429 in first-year total cost, median $759,715.

Most frequent study sections

  1. HIV Coinfections and HIV Associated Cancers Study Section[HCAC]2

Most frequent institutions

  1. CORNELL UNIVERSITY1
  2. JOHNS HOPKINS UNIVERSITY1
Competing awards under PAR-19-307 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020A STINGing vaccine for TB1R01AI155346-01BISHAI, WILLIAM RAMSESMEHRA, SMRITIJOHNS HOPKINS UNIVERSITY, MD$842,441HCAC
2020Lung immune function in human TB infection and its perturbation by HIV-1.1R01AI155319-01MWANDUMBA, HENRY CHARLESRUSSELL, DAVID GCORNELL UNIVERSITY, NY$676,988HCAC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.